{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Helicobacter pylori", "Molecular docking", "Natural product", "Ulcer", "Urease"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38430447", "DateRevised": {"Year": "2024", "Month": "03", "Day": "02"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1007/s10528-024-10709-5"], "ArticleDate": [{"Year": "2024", "Month": "03", "Day": "02"}], "Journal": {"ISSN": "1573-4927", "JournalIssue": {"PubDate": {"Year": "2024", "Month": "Mar", "Day": "02"}}, "Title": "Biochemical genetics", "ISOAbbreviation": "Biochem Genet"}, "ArticleTitle": "D-Glucosamine is a Potential Urease Inhibitor from Middle Eastern Medicinal Plants for Combatting Helicobacter Pylori Infections; a Molecular Docking and Simulation Approach.", "Abstract": {"AbstractText": ["Helicobacter pylori stands as a significant risk factor for both peptic and stomach ulcers. Their resistance to the highly acidic host environment primarily stems from their capability to produce urease, an enzyme that rapidly converts urea into NH3 and CO2. These byproducts are crucial for the bacterium's survival under such harsh conditions. Given the pivotal role of medicinal plants in treating various ailments with minimal side effects, there is an urgent need for a natural drug that can effectively eliminate H. pylori by inhibiting urease. Hence, the current study aims to identify the most potent urease inhibitor among the natural compounds found in Middle Eastern medicinal plants, taking into consideration factors such as optimal affinity, drug-like properties, pharmacokinetic characteristics, and thermodynamic attributes. In total, 5599 ligand conformers from 151 medicinal plants were subjected to docking against the urease's active site. The top-ranking natural compounds, as determined by their high docking scores, were selected for further analysis. Among these compounds, D-glucosamine (PubChem code 439,213) exhibited the most interactions with the crucial amino acid residues in the urease's active site. Furthermore, D-glucosamine demonstrated superior absorption, distribution, metabolism, excretion, and toxicity properties compared to other top-ranked candidates. Molecular dynamics simulations conducted over 100 nanoseconds revealed stable root mean square deviations and fluctuations of the protein upon complexation with D-glucosamine. Additionally, the radius of gyration and solvent-accessible surface area values for the D-glucosamine-urease complex were notably lower than those observed in other typical urease-inhibitor complexes. In conclusion, this study provides valuable insights into the potential development of D-glucosamine as a novel urease inhibitor. This promising compound holds the potential to serve as an effective drug for combating H. pylori infections in the near future."], "CopyrightInformation": "\u00a9 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature."}, "AuthorList": [{"Identifier": ["0000-0002-6458-2068"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Animal Production, College of Agriculture, Al-Qasim Green University, 8, Al-Qasim, Babil, 51013, Iraq. mohammed79@agre.uoqasim.edu.iq."}], "LastName": "Al-Shuhaib", "ForeName": "Mohammed Baqur S", "Initials": "MBS"}, {"Identifier": ["0000-0001-8933-0994"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Laboratory Sciences, College of Pharmacy, University of Babylon, Hillah, Babil, 51001, Iraq."}], "LastName": "Hashim", "ForeName": "Hayder O", "Initials": "HO"}, {"Identifier": ["0000-0001-8604-620X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Medicine, University of Warith Al-Anbiyaa, Karbala, 56001, Iraq."}], "LastName": "Al-Shuhaib", "ForeName": "Jafar M B", "Initials": "JMB"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Biochem Genet", "NlmUniqueID": "0126611", "ISSNLinking": "0006-2928"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Akada JK, Shirai M, Takeuchi H et al (2000) Identification of the urease operon in Helicobacter pylori and its control by mRNA decay in response to pH. Mol Microbiol 36:1071\u20131084", "ArticleIdList": ["10844692", "10.1046/j.1365-2958.2000.01918.x"]}, {"Citation": "Al-Shuhaib MBS, Hashim HO, Al-Shuhaib JMB (2021a) Epicatechin is a promising novel inhibitor of SARS-CoV-2 entry by disrupting interactions between angiotensin-converting enzyme type 2 and the viral receptor binding domain: a computational/simulation study. Comput Biol Med 141:105155. https://doi.org/10.1016/j.compbiomed.2021.105155", "ArticleIdList": ["10.1016/j.compbiomed.2021.105155", "34942397", "8679518"]}, {"Citation": "Al-Shuhaib MBS, Hashim HO, Al-Shuhaib JMB (2021b) In silico Discovery of a new potent inhibitor for sterol 14-alpha demethylase as a promising antifungal drug against aspergillus fumigatus infection. Biointerface Res Appl Chem 12:5785\u20135796", "ArticleIdList": ["10.33263/BRIAC125.57855796"]}, {"Citation": "Al-Shuhaib MBS, Hashim HO, Al-Shuhaib JMB, Obayes DH (2022) Artecanin of Laurus nobilis is a novel inhibitor of SARS-CoV-2 main protease with highly desirable druglikeness. J Biomol Struct Dyn 41:2355\u20132367", "ArticleIdList": ["35067202", "10.1080/07391102.2022.2030801"]}, {"Citation": "Al-Shuhaib MBS, Alam S, Khan SA et al (2023a) Masoprocol: a promising candidate for targeting insulin resistance by inhibiting resistin with optimal druglikeness Potentials: an in silico approach. J Biomol Struct Dyn. https://doi.org/10.1080/07391102.2023.2254842", "ArticleIdList": ["10.1080/07391102.2023.2254842", "37965722"]}, {"Citation": "Al-Shuhaib MBS, Alam S, Khan SA et al (2023b) Hemagglutinin 3 and 8 can be the most efficient influenza subtypes for human host invasion; a comparative in silico approach. J Biomol Struct Dyn. https://doi.org/10.1080/07391102.2023.2280674", "ArticleIdList": ["10.1080/07391102.2023.2280674", "37965722"]}, {"Citation": "Asnaashari S, Dastmalchi S, Javadzadeh Y (2018) Gastroprotective effects of herbal medicines (roots). Int J Food Prop 21:902\u2013920", "ArticleIdList": ["10.1080/10942912.2018.1473876"]}, {"Citation": "Awaad AS, El-Meligy RM, Soliman GA (2013) Natural products in treatment of ulcerative colitis and peptic ulcer. J Saudi Chem Soc 17:101\u2013124", "ArticleIdList": ["10.1016/j.jscs.2012.03.002"]}, {"Citation": "Ayala G, Escobedo-Hinojosa WI, de la Cruz-Herrera CF, Romero I (2014) Exploring alternative treatments for Helicobacter pylori infection. World J Gastroenterol WJG 20:1450", "ArticleIdList": ["24587621", "10.3748/wjg.v20.i6.1450"]}, {"Citation": "Bansal Y, Silakari O (2012) The therapeutic journey of benzimidazoles: a review. Bioorg Med Chem 20:6208\u20136236", "ArticleIdList": ["23031649", "10.1016/j.bmc.2012.09.013"]}, {"Citation": "Bharatam PV (2021) Computer-aided drug design. Drug Discov Dev from Targets Mol to Med 1:137\u2013210"}, {"Citation": "Brenk R, Schipani A, James D et al (2008) Lessons learnt from assembling screening libraries for drug discovery for neglected diseases. ChemMedChem Chem Enabling Drug Discov 3:435\u2013444"}, {"Citation": "Chandrasekaran B, Abed SN, Al-Attraqchi O et al (2018) Computer-aided prediction of pharmacokinetic (ADMET) properties. Dosage form design parameters. Elsevier, New York, pp 731\u2013755", "ArticleIdList": ["10.1016/B978-0-12-814421-3.00021-X"]}, {"Citation": "Colzato LS, Ruiz MJ, van den Wildenberg WPM, Hommel B (2011) Khat use is associated with impaired working memory and cognitive flexibility. PLoS ONE 6:e20602", "ArticleIdList": ["21698275", "3115937", "10.1371/journal.pone.0020602"]}, {"Citation": "Cunha ES, Chen X, Sanz-Gaitero M et al (2021) Cryo-EM structure of Helicobacter pylori urease with an inhibitor in the active site at 2.0 \u00c5 resolution. Nat Commun 12:1\u20138", "ArticleIdList": ["10.1038/s41467-020-20485-6"]}, {"Citation": "El-Dien RTM, Maher SA, Abdelmohsen UR et al (2020) Antiulcer secondary metabolites from Elaeocarpus Grandis, family Elaeocarpaceae, supported by in silico studies. RSC Adv 10:34788\u201334799", "ArticleIdList": ["10.1039/D0RA06104B"]}, {"Citation": "Essmann U, Perera L, Berkowitz ML et al (1995) A smooth particle mesh Ewald method. J Chem Phys 103:8577\u20138593", "ArticleIdList": ["10.1063/1.470117"]}, {"Citation": "Follmer C (2010) Ureases as a target for the treatment of gastric and urinary infections. J Clin Pathol 63:424\u2013430", "ArticleIdList": ["20418234", "10.1136/jcp.2009.072595"]}, {"Citation": "Friesner RA, Banks JL, Murphy RB et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47:1739\u20131749", "ArticleIdList": ["15027865", "10.1021/jm0306430"]}, {"Citation": "Galvin R, Cousins G, Boland F et al (2013) Prescribing patterns of glucosamine in an older population: a national cohort study. BMC Complement Altern Med 13:1\u20136", "ArticleIdList": ["10.1186/1472-6882-13-316"]}, {"Citation": "Ge R-G, Wang D-X, Hao M-C, Sun X-S (2013) Nickel trafficking system responsible for urease maturation in Helicobacter pylori. World J Gastroenterol WJG 19:8211", "ArticleIdList": ["24363511", "10.3748/wjg.v19.i45.8211"]}, {"Citation": "Ha N-C, Oh S-T, Sung JY et al (2001) Supramolecular assembly and acid resistance of Helicobacter pylori urease. Nat Struct Biol 8:505\u2013509", "ArticleIdList": ["11373617", "10.1038/88563"]}, {"Citation": "Harrach MF, Drossel B (2014) Structure and dynamics of TIP3P, TIP4P, and TIP5P water near smooth and atomistic walls of different hydroaffinity. J Chem Phys 140:174501", "ArticleIdList": ["24811640", "10.1063/1.4872239"]}, {"Citation": "Harvey MJ, De Fabritiis G (2009) An implementation of the smooth particle mesh Ewald method on GPU hardware. J Chem Theory Comput 5:2371\u20132377", "ArticleIdList": ["26616618", "10.1021/ct900275y"]}, {"Citation": "Hassan STS, \u0160udomov\u00e1 M (2017) The development of urease inhibitors: what opportunities exist for better treatment of Helicobacter pylori infection in children? Children 4:2", "ArticleIdList": ["28054971", "5296663", "10.3390/children4010002"]}, {"Citation": "Khan S, Ullah H, Rahim F et al (2023) Synthesis, biological evaluation and molecular docking study of pyrimidine based thiazolidinone derivatives as potential anti-urease and anti-cancer agents. J Saudi Chem Soc 27:101688", "ArticleIdList": ["10.1016/j.jscs.2023.101688"]}, {"Citation": "Krieger E, Vriend G (2015) New ways to boost molecular dynamics simulations. J Comput Chem 36:996\u20131007", "ArticleIdList": ["25824339", "6680170", "10.1002/jcc.23899"]}, {"Citation": "Krieger E, Nielsen JE, Spronk CAEM, Vriend G (2006) Fast empirical pKa prediction by Ewald summation. J Mol Graph Model 25:481\u2013486", "ArticleIdList": ["16644253", "10.1016/j.jmgm.2006.02.009"]}, {"Citation": "Kuna L, Jakab J, Smolic R et al (2019) Peptic ulcer disease: a brief review of conventional therapy and herbal treatment options. J Clin Med 8:179", "ArticleIdList": ["30717467", "6406303", "10.3390/jcm8020179"]}, {"Citation": "Land H, Humble MS (2018) YASARA: a tool to obtain structural guidance in biocatalytic investigations. Protein Engineering. Springer, Berlin, pp 43\u201367", "ArticleIdList": ["10.1007/978-1-4939-7366-8_4"]}, {"Citation": "Liang B, Yuan Y, Peng X-J et al (2022) Current and future perspectives for Helicobacter pylori treatment and management: from antibiotics to probiotics. Front Cell Infect Microbiol 12:1740", "ArticleIdList": ["10.3389/fcimb.2022.1042070"]}, {"Citation": "Lipinski CA (2004) Lead-and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 1:337\u2013341", "ArticleIdList": ["24981612", "10.1016/j.ddtec.2004.11.007"]}, {"Citation": "Loughlin MF (2003) Novel therapeutic targets in Helicobacter pylori. Expert Opin Ther Targets 7:725\u2013735", "ArticleIdList": ["14640908", "10.1517/14728222.7.6.725"]}, {"Citation": "Minkara MS, Ucisik MN, Weaver MN, Merz KM Jr (2014) Molecular dynamics study of Helicobacter pylori urease. J Chem Theory Comput 10:1852\u20131862", "ArticleIdList": ["24839409", "4020587", "10.1021/ct5000023"]}, {"Citation": "Mobley HLT, Mendz GL, Hazell SL (2001) Helicobacter pylori: physiology and genetics. Washington (DC), ASM Press"}, {"Citation": "Noe MC, Peakman M-C (2017) Drug discovery technologies: Current and future trends. In: S. Chackalamannil, D. Rotella, S.E. Ward (eds) Comprehensive Medicinal Chemistry III, Elsevier, Oxford, pp. 1\u201332"}, {"Citation": "Repetto MG, Llesuy SF (2002) Antioxidant properties of natural compounds used in popular medicine for gastric ulcers. Brazilian J Med Biol Res 35:523\u2013534", "ArticleIdList": ["10.1590/S0100-879X2002000500003"]}, {"Citation": "Roszczenko-Jasi\u0144ska P, Wojty\u015b MI, Jagusztyn-Krynicka EK et al (2018) New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. Future Microbiol 3:435\u2013444"}, {"Citation": "Roszczenko-Jasi\u0144ska P, Wojty\u015b MI, Jagusztyn-Krynicka EK (2020) Helicobacter pylori treatment in the post-antibiotics era\u2014searching for new drug targets. Appl Microbiol Biotechnol 104:9891\u20139905", "ArticleIdList": ["33052519", "7666284", "10.1007/s00253-020-10945-w"]}, {"Citation": "Santhosh S, Mathew PT (2008) Preparation and properties of glucosamine and carboxymethylchitin from shrimp shell. J Appl Polym Sci 107:280\u2013285", "ArticleIdList": ["10.1002/app.27083"]}, {"Citation": "Santhosh S, Anandan R, Sini TK et al (2005) Biochemical studies on the antiulcer effect of glucosamine on antioxidant defense status in experimentally induced peptic ulcer in rats. J Clin Biochem Nutr 37:61\u201366", "ArticleIdList": ["10.3164/jcbn.37.61"]}, {"Citation": "Takeuchi H, Trang VT, Morimoto N et al (2014) Natural products and food components with anti-helicobacter pylori activities. World J Gastroenterol WJG 20:8971", "ArticleIdList": ["25083070"]}, {"Citation": "Tarsia C, Danielli A, Florini F et al (2018) Targeting Helicobacter pylori urease activity and maturation: In-cell high-throughput approach for drug discovery. Biochim Biophys Acta (BBA)-General Subj 1862:2245\u20132253", "ArticleIdList": ["10.1016/j.bbagen.2018.07.020"]}, {"Citation": "Uprety B, Chandran R, Arderne C, Abrahamse H (2022) Anticancer activity of urease mimetic cobalt (III) complexes on A549-lung cancer cells: targeting the acidic microenvironment. Pharmaceutics 14:211", "ArticleIdList": ["35057107", "8780642", "10.3390/pharmaceutics14010211"]}, {"Citation": "Valenzuela-Valderrama M, Cerda-Opazo P, Backert S et al (2019) The helicobacter pylori urease virulence factor is required for the induction of hypoxia-induced factor-1\u03b1 in gastric cells. Cancers (Basel) 11:799", "ArticleIdList": ["31185594", "10.3390/cancers11060799"]}, {"Citation": "Zhang H, Jiang Q, Gong G et al (2023) Alpinetin: anti-human gastric cancer potential and urease inhibition activity in vitro. Arch Med Sci AMS 19:1479", "ArticleIdList": ["37732032", "10.5114/aoms/138832"]}]}], "History": [{"Year": "2023", "Month": "9", "Day": "3"}, {"Year": "2024", "Month": "1", "Day": "19"}, {"Year": "2024", "Month": "3", "Day": "2", "Hour": "12", "Minute": "50"}, {"Year": "2024", "Month": "3", "Day": "2", "Hour": "12", "Minute": "50"}, {"Year": "2024", "Month": "3", "Day": "2", "Hour": "11", "Minute": "16"}], "PublicationStatus": "aheadofprint", "ArticleIdList": ["38430447", "10.1007/s10528-024-10709-5", "10.1007/s10528-024-10709-5"]}}]}